X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs SUVEN LIFE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA SUVEN LIFE SHASUN PHARMA/
SUVEN LIFE
 
P/E (TTM) x 123.9 14.0 884.4% View Chart
P/BV x 8.5 3.3 256.4% View Chart
Dividend Yield % 0.2 0.5 44.3%  

Financials

 SHASUN PHARMA   SUVEN LIFE
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
SUVEN LIFE
Mar-17
SHASUN PHARMA/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs94229 41.2%   
Low Rs46151 30.2%   
Sales per share (Unadj.) Rs214.242.7 501.6%  
Earnings per share (Unadj.) Rs5.36.9 77.9%  
Cash flow per share (Unadj.) Rs15.88.5 185.4%  
Dividends per share (Unadj.) Rs1.001.00 100.0%  
Dividend yield (eoy) %1.40.5 271.5%  
Book value per share (Unadj.) Rs53.352.4 101.8%  
Shares outstanding (eoy) m56.62127.28 44.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.34.4 7.3%   
Avg P/E ratio x13.127.7 47.3%  
P/CF ratio (eoy) x4.422.2 19.9%  
Price / Book Value ratio x1.33.6 36.2%  
Dividend payout %18.714.6 128.4%   
Avg Mkt Cap Rs m3,95824,158 16.4%   
No. of employees `000NA1.0 0.0%   
Total wages/salary Rs m2,164522 414.7%   
Avg. sales/employee Rs ThNM5,349.7-  
Avg. wages/employee Rs ThNM513.5-  
Avg. net profit/employee Rs ThNM858.1-  
INCOME DATA
Net Sales Rs m12,1275,435 223.1%  
Other income Rs m229211 108.7%   
Total revenues Rs m12,3565,646 218.8%   
Gross profit Rs m1,0091,291 78.2%  
Depreciation Rs m594214 277.3%   
Interest Rs m41557 730.8%   
Profit before tax Rs m2301,231 18.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-73359 -20.3%   
Profit after tax Rs m302872 34.7%  
Gross profit margin %8.323.7 35.0%  
Effective tax rate %-31.729.2 -108.6%   
Net profit margin %2.516.0 15.5%  
BALANCE SHEET DATA
Current assets Rs m6,8844,917 140.0%   
Current liabilities Rs m8,4561,186 713.0%   
Net working cap to sales %-13.068.6 -18.9%  
Current ratio x0.84.1 19.6%  
Inventory Days Days6262 99.2%  
Debtors Days Days10831 349.4%  
Net fixed assets Rs m4,9703,154 157.6%   
Share capital Rs m113127 89.0%   
"Free" reserves Rs m2,8756,543 43.9%   
Net worth Rs m3,0206,670 45.3%   
Long term debt Rs m1,817259 700.9%   
Total assets Rs m13,3478,157 163.6%  
Interest coverage x1.622.7 6.9%   
Debt to equity ratio x0.60 1,547.9%  
Sales to assets ratio x0.90.7 136.4%   
Return on assets %5.411.4 47.2%  
Return on equity %10.013.1 76.5%  
Return on capital %13.318.6 71.7%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,8434,996 116.9%   
Fx outflow Rs m2,173959 226.6%   
Net fx Rs m3,6694,037 90.9%   
CASH FLOW
From Operations Rs m3981,088 36.5%  
From Investments Rs m-1,635-3,107 52.6%  
From Financial Activity Rs m1,309-300 -435.9%  
Net Cashflow Rs m71-2,319 -3.1%  

Share Holding

Indian Promoters % 39.2 63.4 61.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 0.0 -  
FIIs % 17.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 36.5 108.5%  
Shareholders   20,750 37,287 55.6%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   VENUS REMEDIES  MERCK LTD  NOVARTIS  TTK HEALTHCARE  ORCHID PHARMA LTD  

Compare SHASUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum; Energy and IT Stocks Witness Buying(12:30 pm)

Stock markets in India are presently trading on a positive note. Sectoral indices are trading on a positive note with stocks in the energy sector and IT sector witnessing maximum buying interest.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 8-QTR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS